|
|
 |
MOLECULAR GENETICS TESTS - SPINAL AND BULBAR MUSCULAR ATROPHY |
| |
| |
Background:
X-linked spinal and bulbar muscular atrophy (SBMA, Kennedy disease) is
an adult onset form of motor neurone disease. Since the abnormality is
X-linked, males are affected with females being unaffected carriers.
SBMA is characterised by progressive muscle weakness and atrophy, but
affected males also may have gynaecomastia and reduced fertility,
suggesting a defect in the androgen receptor function. Disease onset is
usually in the fourth to fifth decade of life, and progression is slow.
The human androgen receptor (AR) gene has been mapped to Xq11-12 and
linkage has localised the SBMA gene defect to the same region. The
mutation that causes SBMA is an expansion of the CAG-trinucleotide
repeat located in exon 1 of the androgen receptor gene. The size of the
CAGn in an affected individual is roughly twice that of a normal
individual. Affected alleles have repeat sizes ranging from 36 to 62
repeats, with normal alleles ranging in size from 11 to 34 repeats. In
general, there is a correlation between the CAGn repeat length and
disease severity, with larger repeats present in individuals most
severely affected.
Expanded alleles can undergo alterations in length when transmitted to
the next generation. Due to late onset of this disease, a test capable
of providing a diagnosis during the asymptomatic stages, as well as
during the symptomatic stages can be very useful.
Analysis:
- PCR based analysis of the Androgen receptor gene.
Indications for Testing:
- Confirmation of the clinical diagnosis of SBMA.
- Pre-symptomatic screening for SBMA in individuals with a confirmed family
history of SBMA.
Speciment Requirements:
Blood: 3 x 4.0mL whole blood into EDTA tubes . Invert several times to
mix. Forward within 24-48 hours at ambient temperature.
Paediatric Samples: Minimum of 3mL whole blood in EDTA tubes.
Prenatal Samples:
- Chorionic Villus: Obtain 20mg chorionic villus sample (CVS) and
transfer to a vial containing transport medium.
- Amniotic Fluid: A minimum of 20mL amniotic fluid required. Bloody
specimens may reflect extensive contamination with maternal cells. Such a
specimen may not be suitable for testing.
NOTE:
- Maternal cell contamination is a potential problem when analysing DNA
from CVS samples or cultured amniotic cells. To rule out the presence of
maternal cell contamination a peripheral blood specimen in EDTA from the
mother must be sent with the prenatal sample (minimum 3ml whole blood in
EDTA required).
Tissue: 200 mg of tissue. Specimen must be snap frozen within one hour
of collection. Send specimen frozen on dry ice.
Paraffin blocks of tissue are also acceptable. The tissue sample should
not have had prolonged immersion in formalin before embedding.
NOTE:
- Referral reason plus adequate information and family history must be
submitted with the specimen. Pedigree must be included where appropriate.
Usual test turnaround time:
6 weeks once patient sample/s is received.
Cost of test:
SBMA - $145.53 Note: Prices excludes GST (12.5%)
and may change without notice.
Please click on a link below to view information
about another specific test.
|
|